Compare UTI Focused Fund vs ICICI Prudential Focused Equity Fund
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.96 | 1.69 |
NAV | ₹15.64 | ₹96.86 |
Fund Started | 04 Aug 2021 | 15 Apr 2009 |
Fund Size | ₹2610.46 Cr | ₹14568.53 Cr |
Exit Load | Exit load of 1% if redeemed within 365 days. | Exit load of 1% if redeemed within 1 year |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.96
1.69
NAV
₹15.64
₹96.86
Fund Started
04 Aug 2021
15 Apr 2009
Fund Size
₹2610.46 Cr
₹14568.53 Cr
Exit Load
Exit load of 1% if redeemed within 365 days.
Exit load of 1% if redeemed within 1 year
1 Year | 6.98% | 18.50% |
3 Year | 15.43% | 22.71% |
5 Year | - | 20.19% |
1 Year
6.98%
18.50%
3 Year
15.43%
22.71%
5 Year
-
20.19%
Equity | 98.08% | 97.46% |
Cash | 1.91% | 1.87% |
Equity
98.08%
97.46%
Cash
1.91%
1.87%
Top 10 Holdings |
|
|
Top 10 Holdings
HDFC Bank Ltd. | 9.87% |
ICICI Bank Ltd. | 8.75% |
Infosys Ltd. | 6.00% |
Reliance Industries Ltd. | 5.11% |
Bajaj Finance Ltd. | 4.91% |
Eternal Ltd. | 4.79% |
Larsen & Toubro Ltd. | 4.69% |
Bharti Airtel Ltd. | 4.03% |
Cholamandalam Investment and Finance Company Ltd. | 3.98% |
Maruti Suzuki India Ltd. | 3.84% |
ICICI Bank Ltd. | 7.60% |
HDFC Bank Ltd. | 5.57% |
Infosys Ltd. | 4.83% |
Axis Bank Ltd. | 4.58% |
Sun Pharmaceutical Industries Ltd. | 4.52% |
Godrej Consumer Products Ltd. | 3.92% |
Titan Company Ltd. | 3.90% |
NTPC Ltd. | 3.73% |
Info Edge (India) Ltd. | 3.71% |
Britannia Industries Ltd. | 3.70% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps. | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. |
Launch Date | 04 Aug 2021 | 15 Apr 2009 |
Description
The scheme seeks to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps.
The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap.
Launch Date
04 Aug 2021
15 Apr 2009